-
NICE to reassess Pfizer’s leukaemia drug Besponsa
pharmatimes
January 03, 2018
The National Institute for Health and Care Excellence will reassess Pfizer’s Besponsa (inotuzumab ozogamicin) as a treatment for adults with a certain form of leukaemia.
-
Boston Startup Centrexion by Pfizer's Ex-CEO grants $67M for Ph3 Osteoarthritis Pain Drug
biospace
January 03, 2018
Centrexion Therapeutics closed on a Series D financing worth $67 million to develop its knee osteoarthritis (OA) drug in Phase III.
-
FDA access programmes shaved up to a year off drug approval times, new study shows
pharmafile
December 08, 2017
A research letter published this week has suggested that the FDA initiatives to accelerate drug approvals in the US could have shaved up to almost a year off the regulatory process.
-
FDA improves access to reports of adverse drug reactions
worldpharmanews
September 29, 2017
The U.S. Food and Drug Administration today launched a new user-friendly search tool that improves access to data on adverse events associated with drug and biologic products through the FDA's Adverse Event Reporting System (FAERS).
-
Pfizer’s drug back on the market after proving safety
pharmafile
September 06, 2017
Back in 2000, Pfizer had a drug that was granted accelerated approval for the treatment of acute myeloid leukaemia (AML) and was continued to be used for 10 years.
-
Record number of drug-related deaths, as opioid crisis hits UK
pharmafile
August 03, 2017
Numbers released by the Office for National Statistics (ONC) has revealed that drug misuse deaths were at a record high, with 3,744 deaths in 2016.
-
£50 blood test could predict prostate cancer drug response
pharmatimes
May 05, 2017
Researchers have developed a blood test that could better tailor the treatment of patients with prostate cancer.
-
Novartis scoops up rights to NASH drug
pharmatimes
May 05, 2017
Novartis has exercised an option giving it global development and commercialisation rights to an experimental drug...
-
Cheap drug could prevent thousands of maternal deaths worldwide
pharmafile
April 28, 2017
A drug that has been available to patients for many years may have found a new use to prevent mothers...
-
Indian government goes to war over 75% stent price reduction
pharmafile
April 26, 2017
The National Pharmaceutical Pricing Authority (NPPA), India’s drug pricing regulator, moved to lower the price of the...